Skip to main content

Cytek Biosciences, Inc.

CTKB
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001831915

No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q4 2023 vs. Q3 2023

How the institutions holding Cytek Biosciences, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of CTKB: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders107105−2
Shares77.4M78.9M+1.53M (+2.0%)
Value$427.7M$719.9M+$292.2M (+68.3%)

New holders (18)

Institutions that held Cytek Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to CTKB in Q4 2023
InstitutionSharesValue% of portfolio
Algert Global LLC112,260$1.02M0.04%
Susquehanna International Group, LLP76,108$694.1K0.00%
American Century Companies Inc48,101$438.7K0.00%
Mariner, LLC16,067$146.5K0.00%
CIBC Asset Management Inc10,819$98.7K0.00%
Bank of Montreal10,145$96.4K0.00%
EntryPoint Capital, LLC9,567$87.3K0.08%
Group One Trading, L.P.7,493$68.3K0.00%
Federated Hermes, Inc.3,996$36.4K0.00%
GAMMA Investing LLC1,600$12.1K0.00%
Farther Finance Advisors, LLC807$7.36K0.00%
Leonteq Securities AG620$5.65K0.00%
EverSource Wealth Advisors, LLC132$1.20K0.00%
Russell Investments Group, Ltd.121$1.10K0.00%
Valley National Advisers Inc120$1.00K0.00%
Allworth Financial LP41$3740.00%
Simplex Trading, LLC11$00.00%
Capital Advisors, Ltd. LLC39$00.00%

Sold out (20)

Institutions that held Cytek Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.